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Background: Expectant parents of very preterm infants, physicians, and policy makers 
require estimates for chances of survival and survival without morbidity. Such estimates 
should derive from a large, reliable, and contemporary data base of easily available items 
known at birth.
Objective: To determine short-term outcome and risk factors in very-low-birth-weight 
preterm infants based on administrative data.
Methods: Anonymized routine data sets transmitted from hospital administrations to 
statutory health insurance companies were used to assess survival and survival free of 
major morbidities in a large cohort of preterm infants in Germany.
results: After exclusion of infants with lethal malformations, there were 13,147 infants 
with a birth weight below 1,500 g admitted to neonatal care 2008–2012, of whom 1,432 
infants (10.9%) died within 180 days. Estimated 180 days survival probabilities were 0.632 
(95% confidence interval 0.583–0.677) for infants with 250–499 g birth weight, 0.817 
(0.799–0.834) for 500–749 g, 0.931 (0.920–0.940) for 750–999 g, 0.973 (0.967–0.979) 
for 1,000–1,249 g, and 0.985 (0.981–0.988) for 1,250–1,499 g. Estimated probabilities 
for survival without major morbidity (surgically treated intraventricular hemorrhage, nec-
rotizing enterocolitis, intestinal perforation, or retinopathy) were 0.433 (0.384–0.481) for 
250–499 g, 0.622 (0.600–0.643) for 500–749 g, 0.836 (0.821–0.849) for 750–999 g, 
0.938 (0.928–0.946) for 1,000–1,249 g, and 0.969 (0.964–0.974) for 1,250–1,499 g, 
respectively. Prediction of survival and survival without major morbidities was moderately 
improved by adding sex, small for gestational age, and severe or moderate congenital 
malformation, increasing receiver operating characteristic areas under the curve from 
0.839 (0.827–0.850) to 0.862 (0.852–0.874) (survival) and from 0.827 (0.822–0.842) to 
0.852 (0.846–0.863) (survival without major morbidities), respectively.
conclusion: The present analysis encourages attempts to use administrative data to 
investigate the association between risk factors and outcome in preterm infants.
Keywords: preterm infant, mortality, morbidity, risk factor, predictive power
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inTrODUcTiOn
In threatened preterm delivery at the threshold of viability, 
estimating the chances for survival and survival without major 
morbidities of very preterm infants becomes pivotal when 
parents and physicians are faced with decisions to begin or 
withhold treatment. Furthermore, it is also important when 
designing interventional trials or for making adjustments in 
quality improvement efforts that compare hospital performance. 
Outcome of preterm infants largely depends on birth weight and 
gestational age, and these variables remain the most commonly 
used denominators in population-based reports (1–9). National 
recommendations to initiate or withhold treatment at the thresh-
old of viability are mostly based on gestational age (10), while the 
European Resuscitation Council discourages resuscitative efforts 
in infants below 23 weeks gestational age or those with a birth 
weight below 400 g (11). The likelihood of a favorable outcome 
may be predicted more accurately when further factors present 
at birth are taken into account (12). The U.S. National Institute 
of Child Health and Human Development (NICHD) Neonatal 
Research Network, analyzing data of 4,446 preterm infant with a 
birth weight of 401–1,000 g admitted 1998–2003 to 19 U.S. hos-
pitals, has demonstrated that prediction of survival and survival 
without major neurodevelopmental impairment can be better 
estimated by consideration of five a priori selected factors (birth 
weight, gestational age, sex, exposure to antenatal corticosteroids, 
multiple gestation) than with use of gestational age alone (13). 
Two subsequent population-based studies in Victoria, Australia 
(2005, 114 infants) (14) and California, USA (2005–2008, 4,527 
infants) (15) confirmed that using the five variables gave supe-
rior power to predict mortality than using gestational age only, 
although prediction of mortality for outborns was poor. The 
Canadian Neonatal Network has provided graphical representa-
tions of the probabilities of survival and survival without major 
morbidities calculated from gestational age, birth weight, and 
sex of 17,148 preterm infants admitted 2003–2008 to all major 
level III neonatal intensive care units in Canada, excluding 
only those with lethal congenital anomalies, primary palliation, 
missing values, or extreme outliers (16). The predictive power of 
the model was only marginally improved upon addition of the 
further variables, such as antenatal steroids, multiple gestation, 
mode of delivery, and maternal smoking, while it increased with 
inclusion of variables reflecting the clinical course during the first 
24 h of life (17).
Rates of survival and survival without major morbidities 
vary considerably between countries, and they tend to improve 
over time (4, 7, 8, 18–20). Thus, there is a need to analyze actual 
regional or national data to meet the demand for contemporane-
ous outcome estimates. Here, we report rates of 180 days survival 
and survival free of major morbidities in preterm infants below 
1,500  g birth weight in Germany 2008–2012 based on birth 
weight and assessed the impact of risk factors on outcome of 
these infants.
MaTerials anD MeThODs
In Germany, family health insurance is mandatory for all employ-
ees with an annual income below 53,550 €, including recipients 
of unemployment benefits or welfare. In total, more than 90% 
of the population are covered by this statutory health insurance. 
While individuals can choose freely among 132 statutory health 
insurance providers, regardless of age, morbidities, income, or 
type of employment, there are 11 large regional health care funds 
covering about 33% of the persons insured. These large regional 
health care funds jointly run a scientific institute entrusted 
with collecting routine patient data sets sent from the hospital 
administrations to these 11 statutory health insurance companies 
to obtain reimbursement. The data sets that also contain the date 
the health insurance ends because the patient has died or changed 
the company are analyzed in an anonymized fashion to support 
quality improvement initiatives and provide health policy makers 
with decision aids.
We present an analysis of the data sets of live-born preterm 
infants born between January 1, 2008 and December 31, 2012 
with a birth weight of 250–1,499 g who were admitted to hospital 
care within the first 24 h life and covered by one of the 11 regional 
health care funds. The routine data sets transmitted from the 
hospital administrations to the insurance companies to receive 
reimbursements include diagnoses (ICD-10), major procedures 
(German version of ICPM), sex, and weight on admission (for 
infants below 1 year of age).
We analyzed only data of infants admitted to neonatal care, any 
stillborn infants and intrapartum deaths were excluded, as were 
infants with lethal malformations. Malformations and congenital 
diseases were considered lethal, severe, or moderate according 
to their 180 days mortality rate in very-low-birth-weight infants 
calculated from the regional health care fund data base (>66%, 
lethal: thanatophoric dysplasia, anencephaly, bilateral renal agen-
esis, Potter sequence, autosomal-dominant polycystic kidney 
disease, bladder exstrophy, trisomy 13 or 18, tri- or polyploidy, 
hypoplastic left heart syndrome, double outlet right ventricle, 
aortic atresia, non-immune fetal hydrops; 33–66%, severe: spina 
bifida, urea cycle defects, congenital diaphragmatic hernia, com-
mon arterial trunk, discordant ventriculoarterial connection, 
double inlet ventricle, total anomalous pulmonary venous con-
nection; 16.5–32.9%, moderate: esophageal atresia, omphalocele, 
non-autosomal-dominant polycystic kidney disease, tetralogy 
of Fallot, aortic coarctation, other congenital heart diseases). A 
priori selected predictor variables were birth weight (entered as 
categorical variable per 100 g increments), severe and moderate 
malformations, small for gestational age, sex, and multiple gesta-
tion (8, 12, 13, 21). Endpoints were mortality up to 180 days of life 
(during the first hospitalization, any subsequent hospitalizations, 
or at home) and any surgical interventions performed during the 
first 180 days of life for high-grade intraventricular hemorrhage 
(IVH), necrotizing enterocolitis (NEC)/spontaneous intestinal 
perforation, or retinopathy of prematurity (ROP). Any brain sur-
gery in infants with IVH, such as shunt placement or endoscopic 
Abbreviations: ICD, international classification of diseases; ICPM, international 
classification of procedures in medicine; IVH, intraventricular hemorrhage; NEC, 
necrotizing enterocolitis; NICHD, National Institute of Child Health and Human 
Development; OR, odds ratio; ROC, receiver operator characteristics; ROP, retin-
opathy of prematurity; VEGF, vascular endothelial growth factor.
TaBle 1 | Patients’ characteristics stratified by birth weight.
Total
N (%)
250–499 g
N (%)
500–749 g
N (%)
750–999 g
N (%)
1000–1249 g
N (%)
1,250–1,499 g
N (%)
Number 13,147 (100) 673 (100) 2,147 (100) 2,764 (100) 3,061 (100) 4,502 (100)
Girls 6,473 (49.2) 353 (52.5) 1,090 (50.8) 1,351 (48.9) 1,478 (48.3) 2,201 (48.9)
Small for gestational age 2,502 (19.0) 216 (32.1) 387 (18.0) 434 (15.7) 566 (18.5) 899 (20.0)
Multiple gestation 2,456 (18.7) 94 (14.0) 328 (15.8) 498 (18.0) 556 (18.2) 980 (21.8)
Severe malformations 53 (0.4) 3 (0.5) 7 (0.3) 6 (0.2) 14 (0.5) 23 (0.5)
Moderate malformations 128 (1.0) 13 (1.9) 20 (0.9) 26 (0.9) 23 (0.8) 46 (1.0)
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drainage, was considered surgical intervention, as was drainage 
or laparotomy in infants with NEC or spontaneous intestinal 
perforation. For ROP, cryotherapy, laser treatment, and intra-
vitreal injections of any of the anti-VEGF drugs bevacizumab, 
ranibizumab, aflibercept, or pegaptanib were considered surgical 
interventions.
Statistical analyses were carried out using STATA (Version 
11.2, Stata Corp, College Station, TX, USA). Kaplan–Meier 
analysis was used to describe survival up to 180  days and 
survival without major neonatal morbidity, with strata being 
compared by the log-rank test. The impact of predictor variables 
was assessed with adjusted odds ratios (OR) in multiple logistic 
regression analyses. To describe the power to predict survival 
and survival without major neonatal morbidity, receiver 
operating characteristics (ROC) curves were generated, and 
the areas under the curve with 95% confidence intervals were 
calculated.
The study received institutional review board approval 
(Ethikkommission der Charité Universitätsmedizin Berlin, # 
EA2/136/14). No consent was required as this is a retrospective 
analysis of anonymized data collected according to federal law.
resUlTs
A total of 13,303 infants covered by the regional statutory health 
insurance companies were born between January 1, 2008 and 
December 31, 2012 with a birth weight between 250 and 1,499 g. 
Of these, 156 were excluded (stillborn, n = 17; lethal malforma-
tions: n = 128, twins with identical numbers: n = 17). The charac-
teristics of the 13,147 patients included are given in Table 1. There 
were 143 cases (1.09%) with incomplete data sets due to a change 
of the insurance company within 180 days after birth. There were 
a higher percentage of girls (51.2 vs. 48.7%, p =  0.0216) and 
small-for-gestational-age babies (21.4 vs. 18.4%, p = 0.0004) in 
infants with a birth weight of 250–749 g, as compared to infants of 
750–1,499 g, while the opposite was observed for multiples (11.4 
vs. 20.7%, p = 0.0001).
Mortality within 180 days of life was 10.9% (1,432/13,147) in 
the total group, and 22% (1,229/5,584) in infants below 1,000 g 
birth weight (Table 2). Estimated probabilities (95% confidence 
intervals) of 180  days survival were 0.632 (0.5831–0.677) for 
infants with a birth weight of 250–499  g, 0.817 (0.799-0.834) 
for 500–749  g, 0.931 (0.920–0.940) for 750–999  g, 0.973 
(0.967–0.979) for 1,000–1,249  g, and 0.985 (0.981–0.988) for 
1,250–1,499 g, respectively (Figure 1). On average, 202 (14.1%) 
of deaths occurred between 30 and 180 days of life (Table 2), of 
which 35 (2.4%) were observed after discharge.
Major neonatal morbidities with surgical interventions 
occurred in 1022/13,147 (7.8%) infants. Estimated probabili-
ties of 180  days survival without major morbidity were 0.433 
(0.384–0.481) for 250–499 g, 0.622 (0.600–0.643) for 500–749 g, 
0.836 (0.821–0.849) for 750–999  g, 0.938 (0.928–0.946) for 
1,000–1,249  g, and 0.969 (0.964–0.974) for 1,250–1,499  g, 
respectively (Figure  2). Overall, there were 888  (6.8%), 
123  (0.9%), and 11  (0.08%) infants suffering from one, two, 
or three morbidities, respectively (Figure  3), and 782  (6.7%), 
116  (1.0%), and 10  (0.09%) in survivors (Figure  4). Among 
the 474 infants who had undergone surgery for NEC/intestinal 
perforation, there were 97 deaths (20.5%), as compared to 
15/296 (5.1%) after surgery for IVH, and 11/397 (2.7%) after 
intervention for ROP.
Multiple logistic regression analysis was used to estimate 
the impact of the a priori selected predictor variables birth 
weight (per each 100-g increment, with the group of infants with 
a birth weight of 1,400–1,499 g serving as reference), sex, small 
for gestational age, multiple gestation, moderate, and severe 
congenital malformations, on survival and survival without 
major morbidity (Table 3). Except for multiple gestation, all of 
the a priori selected variables retained a statistically significant 
association with both death and death or survival with major 
morbidity upon multiple regression analysis.
The areas under the ROC to predict survival and survival 
without major morbidity were 0.862 (0.852–0.874) and 0.852 
(0.846-0.863) taking the a priori selected variables into account, 
as compared to 0.839 (0.827–0.850), and 0.827 (0.822–0.842) 
when only birth weight was used (Figure  5). ROC areas were 
smaller when looking only at infants below 1,000 g birth weight 
[full model: 0.800 (0.785–0.815) for survival, 0.785 (0.772–0.797) 
for survival without major morbidity; birth weight only: 0.771 
(0.755–0.786) for survival, 0.746 (0.732–0.760) for survival with-
out major morbidity].
DiscUssiOn
This analysis reports an overall 180 days survival rate of preterm 
infants with a birth weight <1,500 g admitted to neonatal inten-
sive care units in Germany 2008–2012 of 89.1%, with 14.1% of 
deaths occurring between 30 and 180  days of life. Surgically 
treated major morbidities were observed in 7.7% of all very-
low-birth-weight infants, and 7.8% of survivors, respectively. 
FigUre 3 | Venn diagram of major neonatal morbidities with surgical 
intervention (all infants). IVH, intraventricular hemorrhage; NEC, necrotizing 
enterocolitis (including any intestinal perforation); ROP, retinopathy of 
prematurity.
FigUre 2 | Kaplan–Meier estimates for survival up to 180 days 
of life without major morbidity (surgically treated intraventricular 
hemorrhage, necrotizing enterocolitis/intestinal perforation, 
or retinopathy of prematurity) in preterm infants stratified by 
birth weight.
FigUre 1 | Kaplan–Meier estimates for survival up to 180 days of life 
in preterm infants stratified by birth weight.
TaBle 2 | Mortality and major morbidity stratified by birth weight.
Total
N (%)
250–499 g
N (%)
500–749 g
N (%)
750–999 g
N (%)
1,000–1,249 g
N (%)
1,250–1,499 g
N (%)
Numbers (percentage) 13,147 (100) 673 (100) 2,147 (100) 2,764 (100) 3,061 (100) 4,502 (100)
Mortality 
•	 Within 30 days of life 1,230 (9.4) 394 (58.4) 477 (22.2) 195 (7.1) 88 (2.9) 76 (1.7)
•	 Within 180 days of life 1,432 (10.9) 417 (62.0) 565 (26.3) 247 (8.9) 110 (3.6) 93 (2.1)
Major neonatal morbidity
•	 Intraventricular hemorrhage, surgical treatment within 
first 180 days of life
296 (2.3) 13 (1.9) 78 (3.6) 106 (3.8) 59 (1.9) 40 (0.9)
•	 Necrotizing enterocolitis or intestinal perforation, surgical 
treatment within first 180 days of life 
474 (3.6) 43 (6.4) 199 (9.3) 142 (5.1) 57 (1.9) 33 (0.7)
•	 Retinopathy of prematurity, local treatment (cryo, laser,  
anti-VEGF injection) within first 180 days of life
397 (3.0) 60 (8.9) 227 (10.6) 88 (3.2) 18 (0.6) 4 (0.1)
alive at 180 days
•	 Without major morbidity 10,807 (82.2) 174 (25.9) 1,200 (55.9) 2,257 (81.7) 2,841 (92.8) 4,335 (96.3)
•	 With one major morbidity 782 (5.9) 64 (9.5) 322 (15.0) 222 (8.0) 100 (3.3) 74 (1.6)
•	 With more than one major morbidity 126 (1.0) 18 (2.7) 60 (2.8) 38 (1.4) 10 (0.3) 0 (0.0)
•	 Total 11715 (89.1) 256 (38.0) 1582 (73.7) 2517 (91.1) 2957 (96.6) 4409 (97.9)
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Rates of survival strongly declined alongside decreasing birth 
weight, from 97.9% in 1,250–1,499  g birth weight infants to 
38% in infants below 500  g birth weight, while the rates of 
surgically treated major morbidities in survivors increased 
from 1.7 to 32%.
We compared our data with published data of a cohort of 2,207 
infants below 1,500 g birth weight without lethal malformations 
treated in 2010 in a network of 46 tertiary care neonatal units 
in Germany (22). The published survival rate prior to discharge 
in this network-based cohort (90.6%) was virtually identical to 
the 30  days survival rate observed in the 2008–2012 data set. 
We also compared our data with those of cohorts from other 
countries. For infants below 1,000  g birth weight admitted to 
neonatal care, reported survival at 2 years was 70.8% (613/866) 
FigUre 4 | Venn diagram of major neonatal morbidities with surgical 
intervention (survivors only). IVH, intraventricular hemorrhage; NEC, 
necrotizing enterocolitis (including any intestinal perforation); ROP, retinopathy 
of prematurity.
TaBle 3 | Multivariate predictor variables for death or death/survival with major morbidity.
Variable Or death 5–95% ci Or death or survival with major morbidity 5–95% ci
Birth weight (g)
<300 2026.27 265.06–15,489.06 578.61 131.77–2540.60
300––399 269.96 166.15–438.61 288.90 173.14–482.06
400–499 104.05 73.11–148.09 105.93 77.58–144.65
500–599 42.03 30.11–58.66 47.25 35.85–62.28
600–699 20.15 14.51–27.97 26.63 20.53–34.54
700–799 10.76 7.68–15.08 12.15 9.34–15.79
800–899 5.62 3.93–8.06 6.95 5.30–9.11
900–999 4.02 2.82–5.73 4.99 3.83–6.50
1,000–1,099 3.37 2.20–5.17 3.19 2.29–4.46
1,100–1,199 1.92 1.26–2.93 2.44 1.80–3.31
1,200–1,299 1.39 0.90–2.15 1.24 0.88–1.74
1,300–1,399 1.35 0.86–2.11 1.08 0.75–1.56
1,400–1,499 1 (Reference) 1 (Reference)
Male 1.59 1.40–1.82 1.65 1.48–1.85
Small for gestational age 0.24 0.19–0.29 0.23 0.19–0.28
Multiple 1.07 0.90–1.27 1.08 0.94–1.25
Moderate malformation 1.68 1.11–2.55 1.55 1.05–2.29
Severe malformation 17.34 9.52–31.58 11.59 6.29–21.37
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in a Swiss population-based cohort 2000–2008 (7), as com-
pared with 78% (4,355/5,584) 180 days survival in the German 
2008–2012 cohort. Unfortunately, most published reports do 
not provide survival rates by birth weight, and survival figures 
are given at differing time points  –  prior to discharge (4, 19), 
at 1 year (18), or at 2 years of life (9). Some crude comparisons, 
however, are made possible by the similarity of average birth 
weights (730–750  g) in cohorts of preterm infants <27  weeks 
gestation (730–750 g) in Sweden (18), England (4), France (19), 
and the United States (9), and infants <1,000 g birth weight who 
are subject of this study. The published 1-year or 2-year survival 
rates of the infants admitted to neonatal intensive care were 
78.1% (497/636) in the Swedish EXPRESS cohort (2004–2007) 
and 65.0% (2,630/4,046) in the American NICHD network 
(2006–2011), respectively, while survival to discharge was 61.7% 
(1,041/1,686) in the English EPICure2 (2006) cohort and 69.0% 
(552/800) in the French EPIPAGE2 (2011) cohort. Of note, these 
outcome data are influenced by physicians’ and parents’ choices 
on which infants to admit to neonatal care. We assume that the 
lower percentages of boys and multiples we observed in preterm 
infants with 250–749 g birth weight admitted to neonatal care, 
as compared to infants with 750–1,499 g birth weight, are most 
likely a reflection of such choices.
Outcome was strongly related to birth weight, with risks 
for mortality or major morbidity on average doubling for each 
20–25% decrease in birth weight. The impact of birth weight and 
the other a priori selected variables on death and death and major 
morbidity combined was remarkably similar. Multiple gestation 
was not linked to poor outcome, an observation made for recent 
cohorts also in Australia and New Zealand (23). Small for gesta-
tional age was associated with reduced ORs for poor outcome as 
the investigation used birth weight as primary variable, the oppo-
site would have been observed with gestational age as primary 
variable. While sex, small for gestational age, and malformations 
were independently associated with outcome, estimating chances 
for survival and survival without surgical morbidities based on 
birth weight alone was only slightly improved by the addition of 
these further variables. This is in line with previous observations, 
showing that birth weight alone was only slightly inferior than 
the clinical risk index for babies calculated from birth weight, 
gestational age, congenital malformations, base excess, and 
oxygen requirements during the first 12  h of life in predicting 
death or neurodevelopmental impairment at 1 year of age (24). 
The predictive power, as measured by the area under the ROC 
curve, was similar to that of similar published algorithms taking 
FigUre 5 | receiver operating characteristic (rOc) curve for survival 
(upper panel) or survival without major morbidities (lower panel) 
based on birth weight (model 1, dashed lines) or birth weight, small 
for gestational age, sex, multiple gestation, severe or moderate 
malformations (model 2, solid lines).
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only variables into account that are known at birth (13, 16). 
Unfortunately, the lack of certain items in the data set available 
prevented any direct head-to-head comparison.
This study has several strengths and weaknesses. It is based 
on a large, contemporary cohort, with limited selection bias or 
loss to follow-up. Well-to-do individuals, however, are under-
represented in the cohort of the study, as self-employed persons 
and employees with an annual income above 53,550 € may choose 
private health insurance instead of statutory health insurance 
(about 10% of the population). This drawback is to be balanced 
against the risk of recruitment bias in prospective clinical trials, 
especially those that require antenatal parental consent (25), the 
risk of referral bias for data from networks of highly specialized 
groups of neonatal intensive care units, and bias introduced into 
observational studies by uneven loss to follow-up, with an excess 
of children from disadvantaged families who are not being evalu-
ated face to face (26).
Our investigation was based on data from patients rather 
than cases, whereas events occurring after discharge or transfer 
to another hospital are being missed in unit-based network and 
quality improvement data sets. In contrast to other studies, the 
180 days window allowed to take events after discharge or transfer 
to another hospital into account, unless there was a change in 
the company providing health care insurance. Late deaths are an 
important issue, especially in very small infants, with 13.3% of 
deaths occurring after 30 days of life in infants below 1,000 g birth 
weight. For comparison, 17.3 and 19.8% of all deaths occurred 
beyond 28 days of life in the American NICHD (8) and English 
EPICure2 cohorts (4), respectively.
As a major weakness, some variables of great interest to clini-
cians are missing, particularly gestational age at birth, antenatal 
steroids, mode of delivery, and inborn/outborn status. A merger 
of the anonymized infant administrative data sets, as used in this 
study, with maternal records is being hampered by current rules 
governing privacy protection. The variable “small for gestational 
age” partly made up for the missing variable “gestational age at 
birth,” also avoiding the multicollinearity problem when birth 
weight and gestational age are entered simultaneously as continu-
ous measures. The variable “antenatal steroids” has lost statistical 
impact as a result of the high rates of antenatal steroids and exog-
enous surfactant replacement therapy (27). As data verification 
or central review is not possible with anonymized data sets, we 
chose simple endpoints each representing an irreversible event 
marked with a calendar date (mortality, surgery for neonatal 
diseases) to reduce the risk of reporting bias. This also allowed for 
Kaplan–Meier analyses not possible with time varying variables 
that wax and wane during the clinical course, such as ROP or 
bronchopulmonary dysplasia.
High-grade IVH, high-grade ROP, and NEC requiring 
surgery have been shown to be strong predictors of long-term 
neurodevelopmental impairment (7, 28–35). The high inter-
rater variability of disease severity for IVH, ROP, or NEC argues 
against their use as outcome measures, unless the severity is 
validated by a procedure. IVH, ROP, and NEC are diseases strik-
ing preterm infants with various intensities, and the presence of 
surgical interventions to treat these diseases was used to deline-
ate severe from mild stages. This assumption may not be true 
in all cases, and counting only morbidity linked with a surgical 
intervention likely results in overestimation of survival without 
severe morbidity. However, as surgical procedures increase 
reimbursements paid to hospitals, the use of interventions as an 
outcome variable entails little risk of underreporting, in contrast 
to the mere diagnoses IVH, ROP, and NEC that are liable to 
down-coding. Abnormal cranial ultrasound findings may give 
misleading results, considering the high interobserver variability 
in assessment of cranial ultrasound findings (36, 37) and the 
poor correlation between high-grade IVH, as depicted by early 
cranial ultrasound, and neurodevelopmental impairment (37, 
38). The association between NEC and poor neurodevelopmen-
tal outcome appears to be confined to infants with NEC-related 
abdominal surgery (29).
Data entered into any type of registry are liable to inad-
vertent mistakes, biased coding, or even wilful deceit. When 
estimating the risk of false entries, there are several questions 
to be addressed: (1) How reliable is the information given to 
the person who enters the data? (2) How likely are errors 
based on negligence? (3) Are there incentives for up-coding, 
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down-coding, or omission of data? For these reasons, we chose 
to not include bronchopulmonary dysplasia as an outcome 
variable in this analysis, as it lacks an unambiguous marker to 
disassociate mild from severe forms unless strict definitions are 
being employed. Some degree of disordered lung development 
is common in very preterm infants, and it largely depends on 
the exact criteria used whether or not infants are classified as 
having bronchopulmonary dysplasia (39). For mortality, which 
is at center stage of this analysis, administrative data of insurance 
companies are probably better than data from anywhere else, 
as the death of a patient also implies the end of the insurance 
contract. By contrast, an analysis of the mandatory German neo-
natal registries (used to compare the performance of individual 
units) showed that more than 30% of extremely preterm infants 
born alive (by official birth registry) were not included in these 
registries (40).
Administrative data have been used successfully for as diverse 
purposes as to estimate live delivery rates after tubal sterilization 
reversal (41), to compare the risk of preterm birth among women 
living with and without HIV infection (42), to calculate the risk 
of hospital readmission among infants with neonatal abstinence 
syndrome (43), or to examine patterns of pediatric emergency 
department visits (44, 45). The present analysis encourages 
attempts to use administrative data also to investigate the associa-
tion between risk factors and outcome in preterm infants. When 
it comes to deciding which data to include in such administra-
tive data sets, clinicians should be consulted to facilitate such 
investigations.
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